How many institutions held TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in Q4 2021?

109 institutional investors reported TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value for Q4 2021. Use the holders table for investor-level position and value details.

Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH)

Q: What does CUSIP G8807B106 represent in this 13F holders report?

CUSIP G8807B106 is the security identifier for TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value used to aggregate holder disclosures.

CUSIP: G8807B106

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Ordinary Share $0.00001 Par Value
Shares outstanding: 51,428,000
Total 13F shares: 59,337,727
Share change: -1,321,897
Total reported value: $655,471,603
Put/Call ratio: 856%
Price per share: $11.05
Number of holders: 109
Value change: -$7,845,717
Number of buys: 64
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP G8807B106?
CUSIP G8807B106 identifies TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP G8807B106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAUPOST GROUP LLC/MA	13F	Company	27%	13,660,168	$101,085,000	—	30 Sep 2021	13F
ORBIMED ADVISORS LLC	13F	Company	11%	5,895,159	$43,624,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	11%	5,856,555	$43,339,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	9.9%	5,104,459	$37,772,000	—	30 Sep 2021	13F
Madison Avenue Partners, LP	13F	Company	9.6%	4,929,423	$36,478,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	6.6%	3,405,602	$25,201,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	5.2%	2,670,881	$19,764,000	—	30 Sep 2021	13F
Camber Capital Management LP	13F	Company	4.9%	2,500,000	$18,500,000	—	30 Sep 2021	13F
Woodline Partners LP	13F	Company	3.8%	1,979,130	$14,646,000	—	30 Sep 2021	13F
Chescapmanager LLC	13F	Company	3.7%	1,892,452	$14,004,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	2.7%	1,372,247	$10,155,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.8%	945,534	$6,997,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.4%	695,504	$5,146,000	—	30 Sep 2021	13F
Rock Springs Capital Management LP	13F	Company	1.3%	687,500	$5,088,000	—	30 Sep 2021	13F
Tekla Capital Management LLC	13F	Company	1.3%	656,296	$4,857,000	—	30 Sep 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	1.3%	645,877	$4,779,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	1.2%	602,638	$4,459,000	—	30 Sep 2021	13F
Frank Pasqualone	3/4/5	SVP, CHIEF BUSINESS OFFICER	— class O/S missing	429,783	$4,422,467	—	19 Nov 2021	3/4/5
Clearline Capital LP	13F	Company	1.1%	577,800	$4,276,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	1%	528,520	$3,910,000	—	30 Sep 2021	13F
Philip D. Worboys	3/4/5	SVP, RESEARCH & TRANSL SCIENCE	— class O/S missing	330,752	$3,403,438	—	19 Nov 2021	3/4/5
D. E. Shaw & Co., Inc.	13F	Company	0.82%	420,051	$3,108,000	—	30 Sep 2021	13F
Bradford J. Shafer	3/4/5	EVP, Gen. Counsel, Secretary	— class O/S missing	277,831	$2,858,881	—	20 Aug 2021	3/4/5
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.68%	351,793	$2,604,000	—	30 Sep 2021	13F
Vijay Sabesan	3/4/5	SVP, TECHNICAL OPERATIONS	— class O/S missing	235,524	$2,423,542	—	19 Nov 2021	3/4/5
GOLDMAN SACHS GROUP INC	13F	Company	0.59%	304,257	$2,252,000	—	30 Sep 2021	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.49%	250,219	$1,852,000	—	30 Sep 2021	13F
NORGES BANK	13F	Company	0.47%	242,494	$1,794,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.45%	233,269	$1,726,000	—	30 Sep 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.43%	220,894	$1,635,000	—	30 Sep 2021	13F
AXA S.A.	13F	Company	0.43%	218,800	$1,619,000	—	30 Sep 2021	13F
MACQUARIE GROUP LTD	13F	Company	0.42%	214,712	$1,589,000	—	30 Sep 2021	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.4%	203,516	$1,506,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.38%	193,519	$1,432,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.34%	176,421	$1,306,000	—	30 Sep 2021	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.34%	175,674	$1,300,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.34%	176,717	$1,256,000	—	30 Sep 2021	13F
Tri Locum Partners LP	13F	Company	0.25%	129,192	$956,000	—	30 Sep 2021	13F
Swiss National Bank	13F	Company	0.23%	119,042	$881,000	—	30 Sep 2021	13F
CM Management, LLC	13F	Company	0.19%	100,000	$740,000	—	30 Sep 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.19%	100,000	$740,000	—	30 Sep 2021	13F
Newtyn Management, LLC	13F	Company	0.19%	97,955	$725,000	—	30 Sep 2021	13F
ZAZOVE ASSOCIATES LLC	13F	Company	0.18%	91,669	$678,000	—	30 Sep 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.15%	75,440	$558,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.14%	70,735	$523,000	—	30 Sep 2021	13F
CREDIT SUISSE AG/	13F	Company	0.14%	69,588	$516,000	—	30 Sep 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.13%	67,980	$501,000	—	30 Sep 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.13%	65,600	$485,000	—	30 Sep 2021	13F
GROUP ONE TRADING LLC	13F	Company	0.13%	65,058	$481,000	—	30 Sep 2021	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.13%	64,500	$477,301	—	30 Sep 2021	13F

Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q4 2021

As of 31 Dec 2021, Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 59,337,727 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, Madison Avenue Partners, LP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, BlackRock Inc., Weiss Asset Management LP, FMR LLC, MORGAN STANLEY, STATE STREET CORP, and Chescapmanager LLC. This page lists 110 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

111

Q4 2021 holders

109

Holder diff

-2

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.